Nordic Nanovector

Nordic Nanovector

Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.

Launch date
Employees
Market cap
€32.2m
Enterprise valuation
€23m (Public information from Jun 2023)
Oslo Norway (HQ)
Authorizing premium user...